![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PATL1 | Human | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of PATL1 mRNA | CTD | PMID:23649840 | PATL1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PATL1 mRNA | CTD | PMID:22206623 | PATL1 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Patl1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PATL1 mRNA | CTD | PMID:22206623 | PATL1 | Human | 17alpha-ethynylestradiol | affects expression | ISO | Patl1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of PATL1 mRNA | CTD | PMID:17555576 | PATL1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | PATL1 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | Patl1 (Mus musculus) | 6480464 | [Flame Retardants results in increased abundance of 2 more ... | CTD | PMID:38995820 | PATL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Patl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PATL1 mRNA | CTD | PMID:21570461 | PATL1 | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of PATL1 mRNA | CTD | PMID:30851411 | PATL1 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of PATL1 mRNA | CTD | PMID:21179406 | PATL1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:28628672 | PATL1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:28628672 | PATL1 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Patl1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:36041667 | PATL1 | Human | aflatoxin B1 | increases expression | ISO | Patl1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PATL1 mRNA | CTD | PMID:19770486 | PATL1 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PATL1 mRNA | CTD | PMID:33167477 | PATL1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of PATL1 mRNA | CTD | PMID:33212167 | PATL1 | Human | arsane | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of PATL1 promoter | CTD | PMID:21291286 | PATL1 | Human | arsenic atom | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of PATL1 promoter | CTD | PMID:21291286 | PATL1 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PATL1 promoter | CTD | PMID:27901495 | PATL1 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PATL1 mRNA | CTD | PMID:29275510 | PATL1 | Human | bisphenol A | multiple interactions | ISO | Patl1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:36041667 | PATL1 | Human | bisphenol A | increases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of PATL1 mRNA | CTD | PMID:30816183 and PMID:32528016 | PATL1 | Human | bisphenol F | multiple interactions | ISO | Patl1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:36041667 | PATL1 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA | CTD | PMID:35301059 | PATL1 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PATL1 mRNA | CTD | PMID:35301059 | PATL1 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of PATL1 mRNA | CTD | PMID:25979313 | PATL1 | Human | chlorpyrifos | increases expression | ISO | Patl1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PATL1 mRNA | CTD | PMID:37019170 | PATL1 | Human | choline | multiple interactions | ISO | Patl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PATL1 gene | CTD | PMID:20938992 | PATL1 | Human | crocidolite asbestos | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of PATL1 mRNA | CTD | PMID:29279043 | PATL1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of PATL1 mRNA | CTD | PMID:25562108 | PATL1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:28628672 | PATL1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of PATL1 mRNA | CTD | PMID:37042841 | PATL1 | Human | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of PATL1 mRNA | CTD | PMID:28302478 | PATL1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA | CTD | PMID:27188386 | PATL1 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of PATL1 mRNA | CTD | PMID:29803840 | PATL1 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PATL1 protein | CTD | PMID:23301498 | PATL1 | Human | fenthion | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of PATL1 mRNA | CTD | PMID:34813904 | PATL1 | Human | fenvalerate | increases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of PATL1 mRNA | CTD | PMID:30307764 | PATL1 | Human | folic acid | multiple interactions | ISO | Patl1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | PATL1 | Human | folic acid | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PATL1 mRNA | CTD | PMID:25629700 | PATL1 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of PATL1 protein | CTD | PMID:37730182 | PATL1 | Human | gentamycin | increases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PATL1 mRNA | CTD | PMID:33387578 | PATL1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PATL1 mRNA | CTD | PMID:28628672 | PATL1 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of PATL1 protein | CTD | PMID:32959892 | PATL1 | Human | L-methionine | multiple interactions | ISO | Patl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PATL1 gene | CTD | PMID:20938992 | PATL1 | Human | methidathion | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | methidathion results in decreased expression of PATL1 mRNA | CTD | PMID:34813904 | PATL1 | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of PATL1 mRNA | CTD | PMID:24768652 and PMID:25583101 | PATL1 | Human | paracetamol | affects expression | ISO | Patl1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PATL1 mRNA | CTD | PMID:17562736 | PATL1 | Human | paracetamol | decreases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PATL1 mRNA | CTD | PMID:33387578 | PATL1 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PATL1 mRNA | CTD | PMID:21420995 | PATL1 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PATL1 mRNA | CTD | PMID:19710929 | PATL1 | Human | propiconazole | increases expression | ISO | Patl1 (Mus musculus) | 6480464 | propiconazole results in increased expression of PATL1 mRNA | CTD | PMID:21278054 | PATL1 | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of PATL1 mRNA | CTD | PMID:30851411 | PATL1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PATL1 mRNA | CTD | PMID:23557933 | PATL1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA | CTD | PMID:27188386 | PATL1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of PATL1 mRNA | CTD | PMID:31533062 | PATL1 | Human | tamoxifen | affects expression | ISO | Patl1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of PATL1 mRNA | CTD | PMID:17555576 | PATL1 | Human | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of PATL1 mRNA | CTD | PMID:31758290 | PATL1 | Human | tetrachloromethane | increases expression | ISO | Patl1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PATL1 mRNA | CTD | PMID:31919559 | PATL1 | Human | thioacetamide | increases expression | ISO | Patl1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of PATL1 mRNA | CTD | PMID:34492290 | PATL1 | Human | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of PATL1 mRNA | CTD | PMID:23228038 | PATL1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of PATL1 mRNA | CTD | PMID:37042841 | PATL1 | Human | troglitazone | decreases expression | ISO | Patl1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of PATL1 mRNA | CTD | PMID:28973697 | PATL1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PATL1 mRNA | CTD | PMID:25979313 | PATL1 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PATL1 mRNA | CTD | PMID:27188386 | PATL1 | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of PATL1 mRNA | CTD | PMID:23649840 | |